What is the share price of Godavari Drugs Ltd (GODAVARI) today?
The share price of GODAVARI as on 6th March 2026 is ₹80.10. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Godavari Drugs Ltd (GODAVARI) share?
The past returns of Godavari Drugs Ltd (GODAVARI) share are- Past 1 week: -1.05%
- Past 1 month: -11.28%
- Past 3 months: 9.62%
- Past 6 months: -4.18%
- Past 1 year: -18.48%
- Past 3 years: 2.38%
- Past 5 years: 95.84%
What are the peers or stocks similar to Godavari Drugs Ltd (GODAVARI)?
The peers or stocks similar to Godavari Drugs Ltd (GODAVARI) include:What is the market cap of Godavari Drugs Ltd (GODAVARI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Godavari Drugs Ltd (GODAVARI) is ₹62.52 Cr as of 6th March 2026.What is the 52 week high and low of Godavari Drugs Ltd (GODAVARI) share?
The 52-week high of Godavari Drugs Ltd (GODAVARI) is ₹115 and the 52-week low is ₹69.70.What is the PE and PB ratio of Godavari Drugs Ltd (GODAVARI) stock?
The P/E (price-to-earnings) ratio of Godavari Drugs Ltd (GODAVARI) is 14.27. The P/B (price-to-book) ratio is 1.44.Which sector does Godavari Drugs Ltd (GODAVARI) belong to?
Godavari Drugs Ltd (GODAVARI) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Godavari Drugs Ltd (GODAVARI) shares?
You can directly buy Godavari Drugs Ltd (GODAVARI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Godavari Drugs Ltd
GODAVARI Share Price
BSEGODAVARI Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
GODAVARI Performance & Key Metrics
GODAVARI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 16.90 | 1.44 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.59 | 5.77 | 0.58% |
GODAVARI Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
GODAVARI Company Profile
Godavari Drugs is engaged in the contract manufacturing, loan license manufacturing, manufacturing and supply of active pharmaceutical ingredients (APIs), drug intermediaries and fine chemicals
GODAVARI Forecast
GODAVARI Forecasts
GODAVARI
GODAVARI
Income
Balance Sheet
Cash Flow
GODAVARI Income Statement
GODAVARI Income Statement
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 39.55 | 43.16 | 38.75 | 32.97 | 26.10 | 29.65 | 25.61 | 23.82 | 27.28 | 22.45 | ||||||||||
| Operating & Other expenses | 36.48 | 39.65 | 34.20 | 28.98 | 23.18 | 26.97 | 22.39 | 20.91 | 24.65 | 19.71 | ||||||||||
| EBITDA | 3.07 | 3.51 | 4.55 | 3.99 | 2.92 | 2.68 | 3.22 | 2.91 | 2.63 | 2.74 | ||||||||||
| Depreciation/Amortization | 0.49 | 0.50 | 0.53 | 0.55 | 0.58 | 0.64 | 0.67 | 0.60 | 0.60 | 0.61 | ||||||||||
| PBIT | 2.58 | 3.01 | 4.02 | 3.44 | 2.34 | 2.04 | 2.55 | 2.31 | 2.03 | 2.13 | ||||||||||
| Interest & Other Items | 1.30 | 1.27 | 1.23 | 1.44 | 1.08 | 1.11 | 1.11 | 1.00 | 0.91 | 1.11 | ||||||||||
| PBT | 1.28 | 1.74 | 2.79 | 2.00 | 1.26 | 0.93 | 1.44 | 1.31 | 1.12 | 1.02 | ||||||||||
| Taxes & Other Items | 0.42 | 0.52 | 0.13 | 0.38 | 0.16 | 0.15 | 0.55 | 0.26 | 0.12 | 0.26 | ||||||||||
| Net Income | 0.86 | 1.22 | 2.66 | 1.62 | 1.10 | 0.78 | 0.89 | 1.05 | 1.00 | 0.76 | ||||||||||
| EPS | 1.14 | 1.62 | 3.53 | 2.17 | 1.45 | 1.02 | 1.19 | 1.38 | 1.33 | 1.01 |
GODAVARI Company Updates
GODAVARI Stock Peers
GODAVARI Past Performance & Peer Comparison
GODAVARI Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Godavari Drugs Ltd | 14.27 | 1.44 | — |
| Sun Pharmaceutical Industries Ltd | 39.50 | 5.96 | 0.89% |
| Torrent Pharmaceuticals Ltd | 76.46 | 19.25 | 0.74% |
| Dr Reddy's Laboratories Ltd | 19.20 | 3.20 | 0.61% |
GODAVARI Stock Price Comparison
Compare GODAVARI with any stock or ETFGODAVARI Holdings
GODAVARI Shareholdings
GODAVARI Promoter Holdings Trend
GODAVARI Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
GODAVARI Institutional Holdings Trend
GODAVARI Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
GODAVARI Shareholding Pattern
GODAVARI Shareholding Pattern
GODAVARI Shareholding History
GODAVARI Shareholding History
smallcases containing GODAVARI stock
smallcases containing GODAVARI stock
Looks like this stock is not in any smallcase yet.
GODAVARI Events
GODAVARI Events
GODAVARI Dividend Trend
GODAVARI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
GODAVARI Dividend Trend
GODAVARI has not given any dividends in last 5 years
GODAVARI Dividends
GODAVARI Dividends
GODAVARI Stock News & Opinions
GODAVARI Stock News & Opinions
Net profit of Godavari Drugs declined 1.30% to Rs 0.76 crore in the quarter ended December 2025 as against Rs 0.77 crore during the previous quarter ended December 2024. Sales declined 24.94% to Rs 22.18 crore in the quarter ended December 2025 as against Rs 29.55 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales22.1829.55 -25 OPM %11.148.70 - PBDT1.381.56 -12 PBT0.770.92 -16 NP0.760.77 -1 Powered by Capital Market - Live
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 11 February 2026.Powered by Capital Market - Live
Godavari Drugs announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 February 2026.Powered by Capital Market - Live
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 15 January 2026.Powered by Capital Market - Live
Net profit of Godavari Drugs declined 8.26% to Rs 1.00 crore in the quarter ended September 2025 as against Rs 1.09 crore during the previous quarter ended September 2024. Sales rose 2.15% to Rs 26.65 crore in the quarter ended September 2025 as against Rs 26.09 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales26.6526.09 2 OPM %7.4711.12 - PBDT1.721.83 -6 PBT1.121.25 -10 NP1.001.09 -8 Powered by Capital Market - Live
Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
Godavari Drugs has revised the Annual General Meeting of the company which was scheduled to be held on 28 August 2025. The meeting will now be held on 27 August 2025.Powered by Capital Market - Live
Godavari Drugs announced that the Annual General Meeting(AGM) of the company will be held on 27 September 2025.Powered by Capital Market - Live
Net profit of Godavari Drugs declined 36.20% to Rs 1.04 crore in the quarter ended June 2025 as against Rs 1.63 crore during the previous quarter ended June 2024. Sales declined 26.08% to Rs 23.81 crore in the quarter ended June 2025 as against Rs 32.21 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales23.8132.21 -26 OPM %12.1410.03 - PBDT1.902.56 -26 PBT1.302.01 -35 NP1.041.63 -36 Powered by Capital Market - Live
Godavari Drugs announced that the Annual General Meeting(AGM) of the company will be held on 13 August 2025.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 3.55%, vs industry avg of 9.88%
Over the last 5 years, market share decreased from 0.04% to 0.03%
Over the last 5 years, net income has grown at a yearly rate of 16.86%, vs industry avg of 19.69%